Stericycle (NASDAQ:SRCL) Announces Earnings Results, Beats Expectations By $0.03 EPS

Stericycle (NASDAQ:SRCL) released its quarterly earnings data on Thursday. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03, Briefing.com reports. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The company had revenue of $664.90 million during the quarter, compared to the consensus estimate of $676.42 million. During the same quarter in the prior year, the firm posted $0.49 earnings per share. Stericycle’s revenue for the quarter was down 2.8% on a year-over-year basis. Stericycle updated its FY 2024 guidance to 2.200-2.500 EPS.

Stericycle Stock Performance

Shares of SRCL stock traded down $0.33 during mid-day trading on Friday, hitting $46.18. The stock had a trading volume of 398,635 shares, compared to its average volume of 461,944. The firm has a market cap of $4.28 billion, a PE ratio of -192.95, a PEG ratio of 2.68 and a beta of 1.09. The company’s 50-day simple moving average is $51.42 and its 200-day simple moving average is $48.15. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.94 and a quick ratio of 0.94. Stericycle has a fifty-two week low of $37.78 and a fifty-two week high of $57.06.

Wall Street Analysts Forecast Growth

SRCL has been the topic of a number of research reports. Wells Fargo & Company raised their price target on Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research note on Friday, March 1st. Robert W. Baird cut their target price on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday. Royal Bank of Canada reiterated an “outperform” rating and set a $69.00 price target on shares of Stericycle in a research note on Thursday, March 7th. StockNews.com lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Finally, Truist Financial increased their target price on shares of Stericycle from $50.00 to $57.00 and gave the stock a “hold” rating in a research note on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $60.80.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.